CPT Rallies Hard — But the Street Hasn't Caught Up

The analyst picture reflects a Street caught flat-footed by the rally. Mizuho lifted its target to $125 this morning while maintaining an Outperform — the clearest vote of confidence in the recent move. But the broader analyst community is clustered below current price, with Wells Fargo at $107, UBS at $106, and RBC at $105. Scotiabank downgraded CPT to Sector Underperform in mid-May with a $95 target, a call that looks increasingly challenged. The mean target implies the stock is already trading roughly 1.5% above where the consensus thinks it should be. EV/EBITDA has expanded to 18.3x, up meaningfully over the past month, and the price-to-book ratio has climbed to 3.4x. The bull case rests on 2.6% same-store revenue growth in 2026 and improving expense discipline; the bear case points to a trimmed FFO estimate of $7.05 per share and softening demand in Washington D.C. and Houston.

Positioning in the lending market is loose, which makes the short interest build worth noting. Nearly 6% of the free float is now short — up 11% over the past month — yet borrow conditions remain entirely relaxed. Availability has actually expanded sharply this week, running at over 2,200% — meaning shares to borrow vastly outnumber shares already lent out. Borrowing costs are a modest 0.40%, easing slightly on the week. The short-score reading of 45.8 has drifted lower over the past two weeks, consistent with a modest short rebuild that has not yet attracted aggressive conviction. Options positioning is mildly bullish: the put/call ratio is running at 0.41, below its 20-day average of 0.61, with calls dominating the flow this session after a brief defensive spike mid-week. None of this signals a crowded short or a squeeze setup — it reads more like cautious nibbling against a strong tape.

The insider angle deserves attention. Founder and Executive Chairman Richard Campo sold 30,000 shares on June 5 at $112.42, generating $3.4 million in proceeds. That follows a January sale of nearly 25,000 shares by Campo at just under $110. The 90-day net insider position is entirely sales-side. Campo's moves don't always signal a top — he has been a regular seller for years — but the timing, coming into a stock that has just broken above consensus price targets, is worth registering alongside the Scotiabank downgrade that preceded the rally.

The factor score picture adds nuance. EPS momentum over the past 30 days ranks in the 97th percentile — one of the strongest readings in the universe — yet the 90-day EPS momentum sits at just the 4th percentile, a sharp divergence that suggests very recent estimate revisions have turned positive after a weak stretch. The dividend score ranks at the 91st percentile, consistent with CPT's income-investor appeal. The short-score rank of 20 and utilization rank of 38 reflect a stock that is moderately shorted but far from an extreme positioning story.

The next earnings release is scheduled for July 30. With the stock now above the consensus target and the founder reducing exposure, the key question into that print will be whether 2026 same-store revenue guidance holds firm against continued supply pressure in Sun Belt markets — and whether the recent momentum shift in EPS estimates marks a genuine inflection or a one-month anomaly.